Front Row Advisors LLC Catalent, Inc. Transaction History

Front Row Advisors LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$31.86 - $67.26 $2,580 - $5,448	-81 Reduced 55.1%	66 $3,000
Q1 2023 May 22, 2023	BUY	$45.44 - $74.26 $6,225 - $10,173	137 Added 1370.0%	147 $10,000
Q1 2023 May 15, 2023	SELL	$45.44 - $74.26 $5,407 - $8,836	-119 Reduced 92.25%	10 $15,000
Q4 2022 Feb 15, 2023	BUY	$41.39 - $81.0 $2,193 - $4,293	53 Added 69.74%	129 $6,000
Q3 2022 Nov 15, 2022	SELL	$72.36 - $113.1 $723 - $1,131	-10 Reduced 11.63%	76 $6,000
Q2 2022 Aug 15, 2022	BUY	$87.2 - $114.05 $959 - $1,254	11 Added 14.67%	86 $9,000
Q4 2021 Mar 09, 2022	SELL	$119.57 - $139.07 $119 - $139	-1 Reduced 1.32%	75 $10,000
Q1 2021 Apr 28, 2021	SELL	$101.51 - $125.27 $1,015 - $1,252	-10 Reduced 11.63%	76 $8,000
Q3 2020 Nov 30, 2020	SELL	$72.74 - $92.5 $1,818 - $2,312	-25 Reduced 22.52%	86 $8,000
Q2 2020 Aug 17, 2020	SELL	$48.02 - $79.04 $1,536 - $2,529	-32 Reduced 22.38%	111 $8,000
Q1 2020 May 08, 2020	BUY	$36.95 - $62.95 $960 - $1,636	26 Added 22.22%	143 $10,000
Q3 2019 Nov 08, 2019	BUY	$47.45 - $58.05 $1,328 - $1,625	28 Added 31.46%	117 $6,000
Q4 2018 Feb 13, 2019	SELL	$29.95 - $46.34 $1,647 - $2,548	-55 Reduced 38.19%	89 $3,000
Q2 2018 Jul 31, 2018	BUY	$38.72 - $42.52 $116 - $127	3 Added 2.13%	144 $6,000
Q1 2018 May 21, 2018	BUY	$39.4 - $47.39 $5,555 - $6,681	141 New	141 $6,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Front Row Advisors LLC with notifications on news.